UMIN-CTR Clinical Trial

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000009467
Receipt No. R000011121
Official scientific title of the study Chronic kidney disease-A Prospective study of Treatment for Renal Anemia on Prognosis in hemodialysis patients study.
Date of disclosure of the study information 2012/12/10
Last modified on 2016/08/20 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Chronic kidney disease-A Prospective study of Treatment for Renal Anemia on Prognosis in hemodialysis patients study.
Title of the study (Brief title) CKD-TRAP study
Region
Japan

Condition
Condition Chronic Kidney disease
Classification by specialty
Nephrology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Estimation of the effect of nutritional state, inflammation, anemia, and the treatment on the renal function and cardiovascular disease.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Explanatory
Developmental phase Not applicable

Assessment
Primary outcomes 1) Kidney function
2) Adverse event (Cardiovascular disease, infectious disease, death)
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
75 years-old >
Gender Male and Female
Key inclusion criteria Patients with CKD stage 3-5.
Key exclusion criteria Patients with chronic inflammation or malignant disease.
Target sample size 1000

Research contact person
Name of lead principal investigator Kuragano Takahiro
Organization Hyogo College of Medicine
Division name Department of Internal Medicine
Address 1-1, Mukogawa Cho, Nisinomiya, Hyogo
TEL 0798-45-6521
Email kuragano@hyo-med.ac.jp

Public contact
Name of contact person Kuragano Takahiro
Organization Hyogo College of Medicine
Division name Department of Internal Medicine
Address 1-1, Mukogawa Cho, Nisinomiya, Hyogo
TEL 0798-45-6521
Homepage URL
Email kuragano@hyo-med.ac.jp

Sponsor
Institute Hyogo college of Medicine
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 兵庫医科大学、埼玉医科大学医療センター、香川医科大学、熊本大学、福岡大学、宮崎大学、東邦医科大学

Other administrative information
Date of disclosure of the study information
2012 Year 12 Month 10 Day

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2011 Year 12 Month 01 Day
Anticipated trial start date
2012 Year 12 Month 01 Day
Last follow-up date
2017 Year 12 Month 01 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information Estimation of the relationship between the treatment and renal function, adverse event in chronic kidney disease.

Management information
Registered date
2012 Year 12 Month 03 Day
Last modified on
2016 Year 08 Month 20 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011121